KOBAYASHI PHARMACEUTICAL Aktie

 

Osaka, March 27 (Jiji Press)--Kobayashi Pharmaceutical Co. rejected Friday management reform proposals by the top shareholder in the Osaka-based producer of health problem-causing supplements containing "beni koji" red fermented rice. At the day's general shareholders meeting in the western Japan city, Hong Kong-based investment fund Oasis Management Co., which holds a 13.7 pct stake in Koba......

* Although Oasis generally supports the separation of business execution and oversight, Oasis is calling on shareholders to vote AGAINST Kobayashi Pharma transitioning to a Company with an Audit and Supervisory Committee, as Oasis believes it may further entrench the founding family's control over the Company * Oasis continues to urge all shareholders to vote AGAINST the election of Akihiro Kobayashi and Yoshiro Katae as Directors * Oasis withdrew its proposal to elect Mr. Kawaguchi, as the Company's proposed amendment to its Articles of Incorporation has effectively rendered Oasis's proposal meaningless *Oasis continues to urge all shareholders to vote FOR its other shareholder proposals More information available at www.KobayashiCorpGov.comHONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”) is the manager to funds that beneficially own over 13.1% of Japanese pharmaceuticals and food products manufacturer Kobayashi Pharmaceutical Co., Ltd. (4967 JT) (“Kobayashi Pharma” or the ?...

Tokyo, March 5 (Jiji Press)--A Japanese research team has uncovered a part of the mechanism by which a substance found in Kobayashi Pharmaceutical Co.'s supplements containing "beni koji," or red fermented rice, triggered kidney damage, it was learned Thursday. Although it had been known that puberulic acid derived from blue mold was behind the high-profile health scare involving the supple......

TOKYO (dpa-AFX) - Kobayashi Pharmaceutical Co., Ltd. (KBYPF) announced earnings for full year that Dropped, from last yearThe company's earnings came in at JPY3.656 billion, or JPY49.19 per share.......

TOKYO (dpa-AFX) - Kobayashi Pharmaceutical Co. Ltd.(KBYPF, 4967.T) registered a decline in net profit for the third quarter. However, the company recorded an increase in sales, driven by the full-......

Osaka, Aug. 23 (Jiji Press)--Kobayashi Pharmaceutical Co. said Friday that it has expanded its factory in Georgia to double the production capacity of disposable hand warmers to meet growing demand in the United States. The 8-billion-yen expansion was completed on Aug. 12, the Japanese company said. The expanded facility is expected to go into operation by the end of fiscal 2025. The product......

Kobayashi Pharmaceutical achieved net profit growth for over 20 years from its stock market listing until the beni kо̄ji scandal emerged last year....

Osaka, Aug. 3 (Jiji Press)--Japan's Kobayashi Pharmaceutical Co. will accelerate efforts to reform its corporate culture marked by workers' reliance on top management, Chairman Yoshihito Ota has said. A major problem the drug and supplement maker must address is the "strong tendency to depend on top management," seen among its employees, Ota said in a recent interview. Ota took office in ......

The Osaka-based company has replaced its president twice and appointed an external chairman, seeking to reduce the influence of the founding family seen as a cause of the scandal....

In March 2024, the drugmaker, based in Osaka, announced that it had received a series of reports about such symptoms as kidney disease from users of its supplements....

Osaka, June 4 (Jiji Press)--The head of Kobayashi Pharmaceutical Co. has promised that it will never cause health damage again, following a high-profile scare last year caused by its supplements containing "beni koji," or red fermented rice. "I will continue to urge our workers to never repeat" such health hazards, President and CEO Norikazu Toyoda said in a recent interview held after taki......

Osaka, March 28 (Jiji Press)--Kobayashi Pharmaceutical Co. on Friday promoted executive officer Norikazu Toyoda to its president and CEO after shareholders approved the company's proposed slate of 10 board nominees, including him. Yoshihito Ota, who helped turn around Japan Airlines, became chairman of the scandal-tainted Japanese drugmaker. The changes come as Kobayashi Pharmaceutical, b......

Osaka, March 28 (Jiji Press)--Shareholders of Kobayashi Pharmaceutical Co. on Friday approved the company's proposed slate of 10 board nominees, including executive officer Norikazu Toyoda, who is set to become new president and CEO of the scandal-tainted Japanese company. The 10 also include Yoshihito Ota, who helped turn around Japan Airlines and will become chairman of the drugmaker. T......